WIND-PSC is a patient-led, global, prospective, multi-center observational study that is entirely planned, financed, and overseen by PSC Partners.
WIND-PSC aims to collect regulatory-quality data including extensive clinical data, imaging results, and patient reported outcome measures (PROMs) from up to 2000 patients over five years.
This real-world dataset will be used to support the design of PSC clinical trials and support regulatory filings for new treatments.
The extensive WIND-PSC dataset can help researchers identify relevant biomarkers that can be used in clinical trials for accurately measuring the safety and effectiveness of PSC treatments.
The detailed collection of patient symptoms and experiences through PROM questionnaires in the WIND-PSC study can help researchers connect the data with key disease related events, biomarkers, and PSC progression,
The study is enrolling adults between the ages of 18 and 75 who have a confirmed diagnosis of PSC affecting the large bile ducts.
As new study sites are added to WIND-PSC, they will be listed on the ClinicalTrials.gov study record: NCT06297993.
Posted July 2025
